Development of mi RNA ‐based therapeutic approaches for cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of mi RNA ‐based therapeutic approaches for cancer patients

Published:2019-02-26 Issue:4 Volume:110 Page:1140-1147
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Takahashi Ryou‐u¹²,Prieto‐Vila Marta¹³,Kohama Isaku¹,Ochiya Takahiro¹³^ORCID

Affiliation:

1. Division of Molecular and Cellular MedicineNational Cancer Center Research Institute Tokyo Japan

2. Department of Cellular and Molecular BiologyGraduate School of Biomedical SciencesHiroshima University Hiroshima Japan

3. Institute of Medical ScienceTokyo Medical University Tokyo Japan

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13965

Reference99 articles.

1. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

2. GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability

3. New tricks from old dogs join the fight against ageing

4. The functions of animal microRNAs

5. Identification of targets of tumor suppressor microRNA-34a using a reporter library system

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA, phytometabolites and disease: Connecting the dots;Phytotherapy Research;2024-07-29

2. MicroRNA-138 inhibits hypoxia-inducible factor 1α expression in breast cancer cells;Nucleosides, Nucleotides & Nucleic Acids;2024-07-14

3. Lipid Nanoparticles as a Platform for miRNA and siRNA Delivery in Hepatocellular Carcinoma;Current Drug Delivery;2024-05-02

4. miRNAs Delivery for Cancer-associated Fibroblasts’ Activation and Drug Resistance in Cancer Microenvironment;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-03

5. Clinical value of the expression levels of tumor protein D52 and miR-133a on prognosis assessment of pancreatic cancer surgery;Pakistan Journal of Medical Sciences;2024-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3